LDS/Medical Tests/Immunoglobulin Subclass IgG4

Immunoglobulin Subclass IgG4

IgG Subclass 4 (IgG4) is the least abundant form of IgG, accounting for only 4-6% of total IgG. Like other IgGs, it consists of two antigen-binding Fab arms and an effector-functioning Fc arm. IgG4 is known to interact with the protein A of Staphylococcus aureus but it is incapable of fixing complement. An abnormal level of IgG4 is encountered in various chronic, autoimmune, fibro-inflammatory disorders, referred to collectively as IgG4-Realted disease (IgG4-RD).

Elevated levels of IgG4 were first identified in patients with type 1 autoimmune pancreatitis and has gained worldwide attention. Elevated levels are associated with multi-organ involvement but are particularly increased in disorders related to the neck, aorta, retroperitoneum, and pancreato-biliary tract. Involved organs usually demonstrate focal enlargement with a lymphoplasmacytic infiltrate and storiform fibrosis.

IgG4 is also increased in chronic allergic diseases like asthma where its blocking function provides a protective response lowering the degranulation of mast cells. It is also increased in various autoimmune disorders like rheumatoid arthritis. Low IgG2 usually accompanies IgG4 deficiencies.

Although elevated serum levels of IgG4 are consistent with IgG4-RD they are insufficient to establish the diagnosis. The demonstration of IgG4 positive plasma cells in the associated organ/tissue is the gold standard for the diagnosis of IgG4 related diseases.

  • As an aid in the diagnosis of IgG4 related disorders (IgG4 RD)
  • As an aid in diagnosis of type1 autoimmune pancreatitis

Increased in:

  • Auto-immune diseases
  • Autoimmune pancreatitis
  • Sclerosing cholangitis
  • Mikulicz disease
  • Retroperitoneal fibrosis
  • Rheumatoid arthritis
  • Multiple myeloma
  • Malignancies

Decreased in:

  • Common Variable Immunodeficiency (CVID)
  • Early HIV infection
  • Hypogammaglobulinaemia

1-1 year: < 20mg/dL

1-2 years: < 23 mg/dL

2-4 years: 0.4-49 mg/dL

4-10 years: 0.8-108 mg/dL

10-18 years: 1-111 mg/dL

>18 years: 2.4-121 mg/dL

Immunonephelometry, immunoturbidimetry, immunodiffusion, serum immunotyping, electrophoresis, Particle Concentration Fluorescence Immunoassay (PCFI), ELISA.

Serum (SST or Red top tube).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 30 days
Immunohistochemistry, biopsy, Anti-Neutrophil Cytoplasmic Antibody (ANCA), anti-galectin 3, IgG2, IgG4:IgG ratio, ESR, CRP.
1 to 3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Immunol Rev. 2015; 11:139-59 [PMID: 26497518]
  • BMJ. 2020; 6:369:m1067 [PMID: 32546500]
  • Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019; 1:83-88 [PMID: 30914118]
  • Proc Jpn Acad Ser B Phys Biol Sci. 2018;94(10):412-427. [PMID: 30541967]
  • M.A.H. French. Immunoglobulins in Health and Disease. 1st edition. 1986
  • Gary W. Litman. Immunoglobulins. Comprehensive Immunology. 1st edition. 1978